References
- Amara S, Alotaibi D, Tiriveedhi V. NFAT5/STAT3 interaction mediates synergism of high salt with IL-17 towards induction of VEGF-A expression in breast cancer cells. Oncol Lett 12, 933–943, 2016.10.3892/ol.2016.4713
- Bataller R, Gabele E, Parsons CJ, Morris T, Yang L, Schoonhoven R, Brenner DA, Rippe RA. Systemic infusion of angiotensin II exacerbates liver fibrosis in bile duct-ligated rats. Hepatology 41, 1046–1055, 2005.10.1002/hep.2066515841463
- Bener A, Al-Suwaidi J, Al-Jaber K, Al-Marri S, Elbagi I E. Epidemiology of hypertension and its associated risk factors in the Qatari population. J Hum Hypertens 18, 529–530, 2004.10.1038/sj.jhh.1001691
- Chen X, Cui Z, Zhang F, Chang W, Chen L, Liu L. Angiotensin II and cAMP regulate AT(1)-mRNA expression in rat cardiomyocytes by transcriptional mechanism. Eur J Pharmacol 448, 1–9, 2002.10.1016/S0014-2999(02)01900-312126964
- Cholewa BC, Meister CJ, Mattson DL. Importance of the renin-angiotensin system in the regulation of arterial blood pressure in conscious mice and rats. Acta Physiol Scand 183, 309–320, 2005.10.1111/j.1365-201X.2004.01401.x15743391
- Dai YN, Wang JH, Zhu JZ, Lin JQ, Yu CH, Li YM. Angiotensin-converting enzyme inhibitors/angiotensin receptor blockers therapy and colorectal cancer: a systematic review and meta-analysis. Cancer Causes Control 26, 1245–1255, 2015.10.1007/s10552-015-0617-12608142626081426
- Falconnet C, Bochud M, Bovet P, Maillard M, Burnier M. Gender difference in the response to an angiotensin-converting enzyme inhibitor and a diuretic in hypertensive patients of African descent. J Hypertens 22, 1213–1220, 2004.10.1097/00004872-200406000-0002315167457
- Fan F, Tian C, Tao L, Wu H, Liu Z, Shen C, Jiang G, Lu Y. Candesartan attenuates angiogenesis in hepatocellular carcinoma via downregulating AT1R/VEGF pathway. Biomed Pharmacother 83, 704–711, 2016.10.1016/j.biopha.2016.07.03927470571
- Gunther S, Gimbrone MA Jr, Alexander RW. Regulation by angiotensin II of its receptors in resistance blood vessels. Nature 287, 230–232, 1980.10.1038/287230a06253796
- Harrison-Bernard LM, El-Dahr SS, O’Leary DF, Navar LG. Regulation of angiotensin II type 1 receptor mRNA and protein in angiotensin II-induced hypertension. Hypertension 33, 340–346, 1999.10.1161/01.HYP.33.1.3409931127
- Hayakawa Y, Aoyama T, Yokoyama C, Okamoto C, Komaki H, Minatoguchi S, Iwasa M, Yamada Y, Kawamura I, Kawasaki M, Nishigaki K, Mikami A, Suzuki F, Minatoguchi S. High salt intake damages the heart through activation of cardiac (pro) renin receptors even at an early stage of hypertension. PLoS One 10, e0120453, 2015.10.1371/journal.pone.0120453437056425799069
- He FJ, MacGregor GA. Salt, blood pressure and the renin-angiotensin system. J Renin Angiotensin Aldosterone Syst 4, 11–16, 2003.10.3317/jraas.2003.00112692748
- Herichova I, Soltesova D, Szantoova K, Mravec B, Neupauerova D, Vesela A, Zeman M. Effect of angiotensin II on rhythmic per2 expression in the suprachiasmatic nucleus and heart and daily rhythm of activity in Wistar rats. Regul Pept 186, 49–56, 2013.10.1016/j.regpep.2013.06.01623850797
- Hudson M, Rahme E, Behlouli H, Sheppard R, Pilote L. Sex differences in the effectiveness of angiotensin receptor blockers and angiotensin converting enzyme inhibitors in patients with congestive heart failure--a population study. Eur J Heart Fail 9, 602–609, 2007.10.1016/j.ejheart.2007.02.0011738393217383932
- Igreja B, Pires NM, Wright LC, Soares-da-Silva P. Effects of zamicastat treatment in a genetic model of salt-sensitive hypertension and heart failure. Eur J Pharmacol 842, 125–132, 2019.10.1016/j.ejphar.2018.10.03030401628
- Imai N, Hashimoto T, Kihara M, Yoshida S, Kawana I, Yazawa T, Kitamura H, Umemura S. Roles for host and tumor angiotensin II type 1 receptor in tumor growth and tumor-associated angiogenesis. Lab Invest 87, 189–198, 2007.10.1038/labinvest.370050417318197
- Iwai M, Horiuchi M. Devil and angel in the renin-angiotensin system: ACE-angiotensin II-AT1 receptor axis vs. ACE2-angiotensin-(1-7)-Mas receptor axis. Hypertens Res 32, 533–536, 2009.10.1038/hr.2009.74709193119461648
- Kammerl MC, Richthammer W, Kurtz A, Kramer BK. Angiotensin II feedback is a regulator of renocortical renin, COX-2, and nNOS expression. Am J Physiol Regul Integr Comp Physiol 282, 1613–1617, 2002.10.1152/ajpregu.00464.200112010742
- Kobori H, Harrison-Bernard LM, Navar LG. Expression of angiotensinogen mRNA and protein in angiotensin II-dependent hypertension. J Am Soc Nephrol 12, 431–439, 2001.1118179010.1681/ASN.V123431257305011181790
- Koganti S, Snyder R, Thekkumkara T. Pharmacologic effects of 2-methoxyestradiol on angiotensin type 1 receptor down-regulation in rat liver epithelial and aortic smooth muscle cells. Gend Med 9, 76–93, 2012.10.1016/j.genm.2012.01.008332228922366193
- Koh SL, Ager EI, Christophi C. Liver regeneration and tumour stimulation: implications of the renin-angiotensin system. Liver Int 30, 1414–1426, 2010.10.1111/j.1478-3231.2010.02306.x20633100
- Kostenis E, Milligan G, Christopoulos A, Sanchez-Ferrer CF, Heringer-Walther S, Sexton PM, Gembardt F, Kellett E, Martini L, Vanderheyden P, Schultheiss HP, Walther T. G-protein-coupled receptor Mas is a physiological antagonist of the angiotensin II type 1 receptor. Circulation 111, 1806–1813, 2005.10.1161/01.CIR.0000160867.23556.7D15809376
- Ljungman C, Kahan T, Schioler L, Hjerpe P, Hasselstrom J, Wettermark B, Bostrom KB, Manhem K. Gender differences in antihypertensive drug treatment: results from the Swedish Primary Care Cardiovascular Database (SPCCD). J Am Soc Hypertens 8, 882–890, 2014.10.1016/j.jash.2014.08.01525492831
- Lubel JS, Herath CB, Tchongue J, Grace J, Jia Z, Spencer K, Casley D, Crowley P, Sievert W, Burrell LM, Angus PW. Angiotensin-(1-7), an alternative metabolite of the renin-angiotensin system, is up-regulated in human liver disease and has antifibrotic activity in the bile-duct-ligated rat. Clin Sci (Lond) 117, 375–386, 2009.10.1042/CS2008064719371232
- Lyngso C, Erikstrup N, Hansen JL. Functional interactions between 7TM receptors in the renin-angiotensin system--dimerization or crosstalk? Mol Cell Endocrinol 302, 203–212, 2009.10.1016/j.mce.2008.09.01818930783
- Mao C, Liu R, Bo L, Chen N, Li S, Xia S, Chen J, Li D, Zhang L, Xu Z. High-salt diets during pregnancy affected fetal and offspring renal renin-angiotensin system. J Endocrinol 218, 61–73, 2013.10.1530/JOE-13-0139440609823620529
- Matsusaka T, Niimura F, Shimizu A, Pastan I, Saito A, Kobori H, Nishiyama A, Ichikawa I. Liver angiotensinogen is the primary source of renal angiotensin II. J Am Soc Nephrol 23, 1181–1189, 2012.10.1681/ASN.2011121159338065022518004
- Mitra AK, Gao L, Zucker IH. Angiotensin II-induced upregulation of AT(1) receptor expression: sequential activation of NF-kappaB and Elk-1 in neurons. Am J Physiol Cell Physiol 299, 561–569, 2010.10.1152/ajpcell.00127.2010294431520554912
- Moreira de Macedo S, Guimaraes TA, Feltenberger JD, Sousa Santos SH. The role of renin-angiotensin system modulation on treatment and prevention of liver diseases. Peptides 62, 189–96, 2014.10.1016/j.peptides.2014.10.00525453980
- Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, Das SR, de Ferranti S, Despres JP, Fullerton HJ, Howard VJ, Huffman MD, Isasi CR, Jimenez MC, Judd SE, Kissela BM, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Magid DJ, McGuire DK, Mohler ER 3rd, Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Rosamond W, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Woo D, Yeh RW, Turner MB; American Heart Association Statistics Committee; Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation 133, e38–360, 2016.10.1161/CIR.000000000000036626811276
- Nehme A, Zibara K. Efficiency and specificity of RAAS inhibitors in cardiovascular diseases: how to achieve better end-organ protection? Hypertens Res 40, 903–909, 2017.2868016710.1038/hr.2017.6528680167
- Nelson C, Coady S (eds). The Jackson Heart Study Data Book A Report to the Cohort and Community. NHLBI Health Information Center, Bethesda, 2008.
- Ogihara T, Asano T, Ando K, Chiba Y, Sekine N, Sakoda H, Anai M, Onishi Y, Fujishiro M, Ono H, Shojima N, Inukai K, Fukushima Y, Kikuchi M, Fujita T. Insulin resistance with enhanced insulin signaling in high-salt diet-fed rats. Diabetes 50, 573–583, 2001.1124687710.2337/diabetes.50.3.57311246877
- Os I, Bratland B, Dahlof B, Gisholt K, Syvertsen JO, Tretli S. Female preponderance for lisinopril-induced cough in hypertension. Am J Hypertens 7, 1012–1015, 1994.784861510.1093/ajh/7.11.10127848615
- Ouali R, Berthelon MC, Begeot M, Saez JM. Angiotensin II receptor subtypes AT1 and AT2 are down-regulated by angiotensin II through AT1 receptor by different mechanisms. Endocrinology 138, 725–733, 1997.10.1210/endo.138.2.49529003008
- Rands VF, Seth DM, Kobori H, Prieto MC. Sexual dimorphism in urinary angiotensinogen excretion during chronic angiotensin II-salt hypertension. Gend Med 9, 207–218, 2012.10.1016/j.genm.2012.06.001341983722795463
- Reid IA. The renin angiotensin system: physiology, pathophysiology and pharmacology. Adv Physiol Educ 20, 237–245, 1998.10.1152/advances.1998.275.6.S236
- Rogers JL, Mitchell AR, Maric C, Sandberg K, Myers A, Mulroney SE. Effect of sex hormones on renal estrogen and angiotensin type 1 receptors in female and male rats. Am J Physiol Regul Integr Comp Physiol 292, 794–799, 2007.10.1152/ajpregu.00424.200616990489
- Sandberg K, Ji H. Sex differences in primary hypertension. Biol Sex Differ 3,7, 2012.10.1186/2042-6410-3-7333182922417477
- Santos RA, Simoes E Silva AC, Maric C, Silva DM, Machado RP, de Buhr I, Heringer-Walther S, Pinheiro SV, Lopes MT, Bader M, Mendes EP, Lemos VS, Campagnole-Santos MJ, Schultheiss HP, Speth R, Walther T. Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc Natl Acad Sci U S A 100, 8258–8263, 2003.10.1073/pnas.143286910016621612829792
- Schiffrin EL, Thome FS, Genest J. Vascular angiotensin II receptors in renal and DOCA-salt hypertensive rats. Hypertension 5, 16–21, 1983.10.1161/01.HYP.5.6_Pt_3.V16
- Shapo L, Pomerleau J, McKee M. Epidemiology of hypertension and associated cardiovascular risk factors in a country in transition: a population based survey in Tirana City, Albania. J Epidemiol Community Health 57, 734–749, 2003.10.1136/jech.57.9.734173256812933782
- Simoes E Silva AC, Miranda AS, Rocha NP, Teixeira AL. Renin angiotensin system in liver diseases: Friend or foe? World J Gastroenterol 23, 3396–3406, 2017.10.3748/wjg.v23.i19.3396544207628596676
- Singh R, Singh AK, Alavi N, Leehey DJ. Mechanism of increased angiotensin II levels in glomerular mesangial cells cultured in high glucose. J Am Soc Nephrol 14, 873–880, 2003.10.1097/01.ASN.0000060804.40201.6E12660321
- Slamkova M, Zorad S, Krskova K. Alternative renin-angiotensin system pathways in adipose tissue and their role in the pathogenesis of obesity. Endocr Regul 50, 229–240, 2016.2794117810.1515/enr-2016-002527941178
- Staessen J, Bulpitt CJ, Fagard R, Lijnen P, Amery A. The influence of menopause on blood pressure. J Hum Hypertens 3, 427–433, 1989.2607517
- Steckelings UM, Paulis L, Unger T, Bader M. Emerging drugs which target the renin-angiotensin-aldosterone system. Expert Opin Emerg Drugs 16, 619–630, 2011.10.1517/14728214.2011.61849521905943
- Taurone S, Galli F, Signore A, Agostinelli E, Dierckx RA, Minni A, Pucci M, Artico M. VEGF in nuclear medicine: Clinical application in cancer and future perspectives (Review). Int J Oncol 49, 437–447, 2016.10.3892/ijo.2016.355327277340
- Townsend N, Wilson L, Bhatnagar P, Wickramasinghe K, Rayner M, Nichols M. Cardiovascular disease in Europe: epidemiological update 2016. Eur Heart J 37, 3232–3245, 2016.10.1093/eurheartj/ehw33427523477
- Wei Q, Sun J, Huang J, Zhou HY, Ding YM, Tao YC, He SM, Liu YL, Niu JQ. Prevalence of hypertension and associated risk factors in Dehui City of Jilin Province in China. J Hum Hypertens 29, 64–68, 2015.10.1038/jhh.2014.3224990419
- Ye G, Qin Y, Lu X, Xu X, Xu S, Wu C, Wang X, Wang S, Pan D. The association of renin-angiotensin system genes with the progression of hepatocellular carcinoma. Biochem Biophys Res Commun 459,18–23, 2015.10.1016/j.bbrc.2015.02.03025701390
- Yoshiji H, Kuriyama S, Yoshii J, Ikenaka Y, Noguchi R, Nakatani T, Tsujinoue H, Fukui H. Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats. Hepatology 34, 745–750, 2001.10.1053/jhep.2001.2823111584371
- Yoshiji H, Yoshii J, Ikenaka Y, Noguchi R, Yanase K, Tsujinoue H, Imazu H, Fukui H. Suppression of the renin-angiotensin system attenuates vascular endothelial growth factor-mediated tumor development and angiogenesis in murine hepatocellular carcinoma cells. Int J Oncol 20, 1227–1231, 2002.1201200310.3892/ijo.20.6.1227
- Zhang X, Lassila M, Cooper ME, Cao Z. Retinal expression of vascular endothelial growth factor is mediated by angiotensin type 1 and type 2 receptors. Hypertension 43, 276–281, 2004.1471835110.1161/01.HYP.0000113628.94574.0f14718351
- Zhao Y, Adjei AA. Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor. Oncologist 20, 660–673, 2015.10.1634/theoncologist.2014-0465457178326001391